Abstract Peripheral mononuclear leukocytes from Alzheimer's disease (AD) patients were analyzed by infrared spectroscopy and their spectroscopic properties were compared with those from age-matched healthy controls. Two-dimensional correlation analysis of mean spectra measured at various disease stages shows that the protein secondary structure from AD patients involves β-sheet enrichment and carbonyl intensity increase relative to healthy controls. The area percentages of β-sheets, which were obtained by using a peak ratio second-derivative spectral treatment, were used for receiver operating characteristic (ROC) analysis to distinguish between patients with AD and age-matched healthy controls. The critical concentration and area under the curve (AUC) were determined by this curve analysis which showed a good performance for this quantitative assay. The results were 90% sensitivity and 90.5% specificity for determinations involving mild and moderate AD patients, and 82.1% sensitivity and 90.5% specificity for determinations involving patients at the three AD stages (mild, moderate, and severe). The AUC was greater than 0.85 in both scenarios. Taken together these results show that healthy controls are distinguished from mild and moderate AD patients better than from patients with severe disease and suggest that this infrared analysis is a promising strategy for AD diagnostics.
Introduction
Alzheimer's disease (AD) is the most common form of adult onset dementia and is histopathologically characterized by the presence of senile plaques, neurofibrillary tangles, and synapse loss [1] . The primary components of the senile plaques are polymers of a short peptide-the so-called amyloid-β peptide (Aβ)-derived through proteolytic processing of a ubiquitous transmembrane protein [2, 3] termed β-amyloid precursor protein. Aβ has been shown to induce oxidative stress in various studies [4, 5] ; however, oxidative stress can generate Aβ [6] . In this connection, there is accumulating evidence suggesting that oxidative stress occurs before the onset of symptoms in AD and such oxidative changes are pervasive throughout the body, being detected peripherally [7] [8] [9] [10] . Mitochondrial abnormalities have been shown to be key sources of oxidative stress in AD [11, 12] . Further, increasing evidence implicates Aβ accumulation in mitochondria in AD [13] [14] [15] [16] . In light of this and the increasing evidence that the immunological reaction of leukocytes plays a crucial role in the development of neurodegenerative disorders [17] , mitochondria-containing peripheral cells such as blood mononuclear leukocytes were studied here to investigate possible systemic disorganization in AD.
All of these molecular changes in AD are explained by two hypotheses. The leading hypothesis is the amyloid cascade [18] in which the key pathophysiological event is the cascade of brain amyloid deposition. The two-hit hypothesis [19] maintains that oxidative stress and aberrant mitogenic changes are probably the first molecular modification in AD (prior to amyloid deposition) and that these processes are necessary for disease propagation.
Currently biomarkers are needed for the earlier diagnosis of AD and for the precise AD pathophysiologic subdiagnosis in the new AD diagnostic criteria [20] . Biomarkers are also needed to monitor efficacy of new therapies [21] . However, as a result of the disease's unknown pathogenesis, no effective technique can achieve the early clinical diagnosis of AD. The current behavior test and imaging examination are largely nonspecific and usually must be combined with genetic or protein biomarker tests to allow the effective differential diagnosis of the dementia variants [22] . At present, the analysis of Aβ(1-42), total tau, and phospho-tau-181 in cerebrospinal fluid (CSF) allows the reliable, sensitive, and specific diagnosis of AD. However, the use of these CSF biomarkers is limited because of invasive collection methods, and there is still a high degree of variability between CSF studies [23, 24] . That is the reason why reliable markers are of considerable diagnostic value, and feasible techniques to detect these markers are also of great interest. Among numerous diagnostic techniques in research laboratories, infrared spectroscopy has the advantage of being fast and noninvasive. High-quality infrared spectra can reflect structural properties of molecules and their surroundings, so they can be considered to be "fingerprints" of the specific molecular species [25] . Therefore, the accurate detection of the alterations in peripheral blood leukocytes may be significant for the early diagnosis of AD. By contrast, several routine methods such as Western blotting require complex preparation steps and suffer from poor accuracy and high costs, which hinder their clinical applications.
The aim of this study was to find characteristic spectral features of peripheral blood mononuclear leukocytes from patients with AD that can be useful to sensitively and specifically diagnose AD. To our knowledge, no previous study has been carried out from this point of view. We collected infrared spectra of the aforementioned leukocytes isolated from AD patients and healthy controls. The mean spectra of mild, moderate, and severe AD leukocytes and the controls were analyzed through two-dimensional (2D) correlation spectroscopy, and the resulting bands characteristic of AD leukocytes were evaluated as potential biomarkers for AD.
Experimental

Subjects
The study was performed with patients affected by AD (12 males, 38 females) and with healthy controls (6 young individuals and 14 senile controls), collected and diagnosed by staff at the AD Research Unit of Centro Alzheimer F. Reina Sofía and the Neurology Department of Hospital 12 de Octubre in Madrid. Mild, moderate, and severe dementia were measured through the GDS rating scale and DSM-III-R criteria.
Leukocyte samples
Peripheral blood samples (4 mL) were collected by phlebotomy in BD Vacutainer CPT tubes, containing sodium citrate, and processed within 4 h of procurement. These Vacutainer tubes have a fluid density gradient and barrier gel which after centrifugation-filtration separate lymphocytes and monocytes (mononuclear cells) at the tube top from erythrocytes and neutrophils at the bottom. The tubes were centrifuged at 1,650 g for 20 min at 4°C. The supernatant (resuspended in 8 mL of phosphate buffered saline, PBS) of the vacutainer tube top was collected and centrifuged at 1,000 g for 10 min at 4°C to obtain a pellet. This was then resuspended and centrifuged twice (1,000 g and 1,400 g) for 10 min using successive 10-and 1-mL volumes of PBS for cell dispersion. The final pellet was then resuspended in 0.5 mL of PBS for subsequent infrared analysis.
Fourier transform infrared (FTIR) experiments
Around 100 μL of each leukocyte solution for infrared spectroscopy was deposited on a ZnSe window, spread with a spatula, and allowed to evaporate overnight at 4°C. The infrared spectrum of the resulting film was measured with a Perkin-Elmer 1725X spectrophotometer with 2 cm −1 resolution and obtained as an average of 32 scans. The spectral contributions from residual water vapor in the sample chamber were eliminated using a set of water vapor spectra measured under identical conditions. The subtraction factor was varied until the non-absorbing region above 1,800 cm −1 was featureless, and the resulting spectrum was subsequently smoothed with a nine-point Savitzky-Golay function to reduce the noise. Spectral data were treated with the GRAMS/AI software (Thermogalactic) which includes baseline correction, smoothing, spectral subtraction, Fourier self-deconvolution, and derivative programs. Second-derivative spectra were obtained with Savitzky-Golay derivative function software for a seven data point window.
2D correlation analysis
The mean spectra of leukocytes from healthy controls and mild, moderate, and severe AD patients were used here for 2D correlation analysis. We employed the 2D-Pocha software, written by Dr. Adachi and Dr. Y. Ozaki (Kwansei-Gakuin University, Japan), which was programmed on the basis of the developed algorithm of generalized 2D correlation spectroscopy [26] . This 2D correlation analysis allows the correlation of the dynamic fluctuations of infrared bands in a series of spectra measured at different times. 2D spectra are defined by two independent frequencies, ν 1 (abscissa) and ν 2 (ordinate). The synchronous 2D correlation spectra of dynamic spectral intensity variations represent the simultaneous occurrence of coincidental changes in spectral intensities measured at ν 1 and ν 2 . Correlation peaks appear at both diagonal (auto-peaks) and off-diagonal peaks (cross-peaks). Cross-peaks, which can either be positive or negative, reflect correlated changes of functional groups that occur simultaneously in the same (+) or in the opposite (−) direction. By contrast, the asynchronous 2D correlation representation is characterized by missing autopeaks and asymmetric cross-peaks which reveal uncorrelated (i.e., out-of-phase) behavior of two bands. The time-dependent changes in the spectral intensities are shown as 2D contours, called synchronous and asynchronous maps (S-and A-maps), which correlate in-phase (synchronized) and out-of-phase (unsynchronized) intensity changes at two frequencies respectively. The rules proposed by Noda and Ozaki were used for the analysis of the sign of the peaks in the 2D correlation maps [26] . 2D infrared correlation maps were constructed with the 1,800-1,600 cm −1 region of the averaged spectra measured from healthy controls and patients at the mild, moderate, and severe stages of AD.
Statistical analysis
One-way analysis of variance was done for the elderly healthy controls and AD patients as a function of β-sheet percentages. The Levene test was used to check the equality of variances.
Where the variances were equal, the differences between means were analyzed by the Bonferroni test. Where equality of variances could not be assumed, a Tamhane T2 test was used.
Receiver operating characteristic (ROC) curve analyses were performed using the whole data set of protein β-sheet percentages in order to estimate the sensitivity and specificity at a certain cutoff value. ROC curves were constructed by plotting (1-specificity) versus sensitivity. Both variables were modeled on the AD patients and healthy controls: the sensitivity was defined as the ratio of the number of AD true positive results to the sum of this plus the number of AD false negative results. The specificity was considered as the ratio of the number of AD true negative results to the sum of this plus the number of AD false positive results. Its complement (1-specificity) is therefore the ratio of the number of AD false positive results to the sum of this plus the AD true negative results. The area under the ROC curve (AUC) is an experimental measure of the test accuracy: an AUC value of 0.80 was selected as an acceptable limit of accuracy for screening biomarkers, whereas a value of 0.90 was chosen as an acceptable limit of accuracy for confirmatory biomarkers [27] . All statistical tests and ROC curve analyses were carried out using the software package SPSS® (SPSS Inc., Chicago, IL, USA, version 19).
Results and discussion
Differences among infrared spectra of mononuclear leukocytes from mild, moderate, severe AD and healthy control groups Mean infrared spectra were adopted to find the spectral differences conveniently in order to discuss the possible structural and compositional reasons according to various levels of AD. Figure 1 shows the amide I band mean spectra of healthy senile controls and patients affected by moderate AD. The most prominent spectral difference is located approximately in the 1,640-1,625 cm −1 range where protein β-structure usually appears [28] [29] [30] . To resolve the overlapping band components under the amide I contour, the corresponding second-derivative spectra were calculated and are shown in Fig. 2 . In the AD spectrum, the higher intensity near 1,631 cm −1 relative to healthy controls can be attributed to the formation of amyloid β-sheet structures on the basis of the infrared spectra from AD brain tissue [31] . In studies of isolated amyloid, on aggregation, the peptide can form very strong intermolecular hydrogen bonds because of close alignment of polypeptide chains, resulting in amide I frequencies lower than 1,631 cm −1 (1,628-1,620 cm
) [32] . This discrepancy can be explained by considering that, in situ, the proteins surrounding the amyloid peptides may prevent close alignment of amyloid peptide chains, resulting in the formation of weaker hydrogen bonds and the appearance of an amide I band component at a higher frequency [31] . On the other hand, the increased intensity of the 1,638 cm −1 band (Fig. 2) during AD can be ascribed to β-sheet proteins which generate amide I vibrational modes clustering in the 1,641-1,625 cm −1 range [29, 33] . Thus, the intensity increase of the 1638 and 1,631 cm
bands (Fig. 2 ) during AD can be attributed to β-sheet proteins and amyloid peptides whose different frequencies are inherent to different properties of their β-sheet structures. Thus, although both structural forms are composed of β-sheet structure, the residues present in β-sheet proteins can vary substantially in their ϕ/ψ dihedral angles [34] . This heterogeneity is reduced in amyloid fibrils and these sheets possess more strands and a smaller twist angle [34] . 2D infrared spectroscopy is a very powerful technique for unraveling the highly complicated infrared bands of complex biological systems, such as that studied here, because conventional infrared measurements do not immediately discern the spectral differences for minor structural variations [26] . Thus the 2D infrared correlation analysis of mean spectra of mild, moderate, and severe AD leukocytes and the controls allows for a more detailed identification of subtle spectral changes in the course of AD. The range from 1,800 to 1,600 cm −1 in the 2D infrared spectra (Fig. 3) was chosen owing to the clearer differentiation found compared with the other ranges. The auto-peaks observed on the diagonal represent the vibrational modes that are perturbed in the course of AD. The strongest peak is centered near 1,635 cm −1 and contains contour lines in the 1,640-1,630 cm −1 range, which corresponds to the secondderivative spectral profile with intensity increase during the AD (Fig. 2) . The assignment of this diagonal peak to β-sheet polypeptide backbone is supported by its frequency which falls in the spectral range characteristic of this secondary structure. In addition, this auto-peak is positively correlated with that located at 1,683 cm −1 (Fig. 3) , which is within the spectral range assigned to the high frequency component of β-sheet structure [29] . Several lines of evidence suggest that Aβ are localized in mitochondrial membranes of brain cells, interact with mitochondrial proteins, increase production of reactive oxygen species, and prevent neurons from functioning normally [13] [14] [15] . Another previous study [12] demonstrated that AD is associated with elevated oxidative damage in mitochondria from peripheral lymphocytes, and is consistent with a mitochondrial functional impairment in AD lymphocytes. Similarly, the increased absorption of β-sheet bands found here seems to be associated with oxidative stress. The 2D infrared synchronous map (Fig. 3 ) indeed shows an auto-peak near 1,730 cm
which can be attributed to carbonyl absorption generated by oxidative stress and is positively correlated with the 1,635 cm
auto-peak assigned to protein β-structure. Other spectral changes are reflected through the auto-peaks appearing near 1,656 and 1,665 cm −1 which can be ascribed to α-helices and turns, respectively [29, 30] . These conformational geometries seem to change to β-sheet and/or unordered structure as shown by the auto-peak centered at 1,642 cm
, whose frequency appears in the overlapping edges of the spectral ranges belonging to protein β-sheet (1,623-1,641 cm −1 ) and unordered
(1,642-1,657 cm
) backbone [29, 33] . Fig. 2 Mean second-derivative spectra in the 1,700-1,600 cm −1 region of mononuclear leukocytes from healthy controls (solid line) and patients with moderate AD (dashed line) Fig. 3 Synchronous map generated by mean spectra in the 1,800-1,600 cm −1 region of mononuclear leukocytes from healthy controls and patients with mild, moderate, and severe AD Determination of β-sheet structure and estimation of diagnostic power An advance in solving the problems of quantitative studies of protein infrared spectra came with the introduction of resolution enhancement techniques, such as secondderivative spectroscopy, that allow a sensitivity improvement in the visualization and quantitation of the amide I band components by reducing their bandwidth. A degree of quantitative analysis would be expected in principle from second-derivative spectra because the peak height is proportional to the original peak height, and inversely proportional to the square of the original half-width [35] . Although some difficulties may arise in obtaining second-derivative spectra for quantitative structural analysis because of the complex patterns created by overlapping peaks and sidelobes [36] , it is possible to probe the relative change of specific bands during subtle protein conformation changes [35, 37] , as occurs in the course of AD. Particularly if the original half-width changes little and the centers of the adjacent peaks are at least 8 cm −1 away [35] , this method can be used in quantitatively monitoring the changes of the bands in question. In this connection, the amide I half-width does not exhibit significant changes in the course of AD, and the two β-sheet bands at 1,638 and 1,631 cm −1 are more than 8 cm −1 away from the adjacent bands at 1,652 and 1,619 cm −1 , respectively (Fig. 2) . In addition, to minimize the effect of sidelobes and artifacts, 9-or 11-point SavitzkyGolay smoothing is good enough for a high-quality spectrum at 2 cm −1 resolution. Under these conditions, the area of the β-sheet spectral profile in the 1,645-1,622 cm −1 range was measured relative to the spectral area between approximately 1,675 and 1,622 cm −1 . This last spectral range includes amide I band components of α-helices, β-sheets, turns, and unordered protein backbone [29, 30] and, hence, the aforementioned area ratio must be proportional to the percentage of β-sheets in the protein structure. Two straight lines, considered as baselines, were drawn tangentially between the extreme frequencies of the aforementioned spectral ranges. The means and standard deviations for elderly healthy controls and AD patients are reported in Table 1 , and a graphical comparison of these results as box plots is shown in Fig. 4 . Application of the Levene and Tamhane T2 tests led to the null hypothesis (no difference) being rejected for elderly healthy controls versus mild, moderate, and severe AD patients, showing that significant differences exist between these AD patients and healthy controls. However, nonsignificant differences were found between any pair drawn from the three AD levels studied here. These results are in contrast with those from previous works dealing with determinations of blood plasma levels of Aβ. Thus, studies have shown that plasma Aβ levels can be elevated, reduced, or even unchanged in AD versus healthy controls [38, 39] . On the other hand, recent longitudinal studies have shown that high plasma Aβ(1-42) levels are a risk factor for developing AD; however, there is no agreement that this factor is not sensitive and specific for early diagnosis [40] . Moreover, it has been reported that plasma levels of Aβ are unstable [41] for the following reasons: (a) Aβ expression is influenced by medications; (b) Aβ binds to other proteins and thus becomes trapped; (c) Aβ levels in blood fluctuate over time and among individuals, and might differ in mild, early, and late AD; and (d) blood platelets contain a high amount of Aβ, which directly affects plasma levels. Thus, unlike blood plasma, mononuclear leukocytes seem to offer a stable medium to determine β-sheet structure levels as a function of AD development. ROC curve analysis was developed for the assessment of qualitative diagnostic assays. Figure 5 shows that, in terms of sensitivity, the ROC curve involving healthy controls and mild and moderate AD patients (AUC 0.911) exceeds the ROC curve involving healthy controls and all the AD patients at the three stages considered here (mild, moderate, and severe) (AUC 0.870). Interestingly, these spectroscopic measurements of β-sheet structure levels seem to be more sensitive for earlier stages of AD, namely, mild and moderate stages. In this curve, sensitivity and specificity are 90.0% and 90.5% respectively at the cutoff level of 10.2 area percentage of β-structure. This indicates that an AD patient either at the mild or moderate level has a 90.0% chance of being identified as a true AD patient, whereas a healthy control has 9.5% probability of being misidentified as an AD patient. This curve also presents an AUC value of 0.911, which indicates that, within a binary classification scheme, a randomly selected positive case has a 91.1% probability of obtaining a higher score than a randomly selected negative case. The sensitivity and specificity for the curve involving the three stages of AD were found to be 82.1% and 90.5%, respectively. Thus this curve, in terms of sensitivity, is exceeded by the one involving healthy controls and mild and moderate AD patients, as described above. This could be due to the trend of β-sheet structure level to decrease in the course of AD, particularly from mild to severe stages of AD (Table 1, Fig. 4) . Similarly, blood plasma Aβ levels from transgenic mice were reported to be considerably elevated during the first months of AD and declined substantially thereafter [42] . Our study has some limitations, one of them being the small number of AD patients and controls. Therefore this investigation must be considered as a pilot or preliminary study. The finding of very good sensitivity and specificity will allow us to develop in the near future a large study with greater numbers of AD and control cases and also including patients suffering from amnesic mild cognitive impairment and from other conditions that might give rise to similar β-sheet content in leukocyte proteins.
Conclusions
The use of 2D infrared spectroscopy for analysis of peripheral mononuclear leukocytes has revealed for the first time the main spectral features of these cells extracted from AD patients, namely, stronger intensity of β-sheets and carbonyl bands when compared with age-matched healthy controls. These bands are located in the 1,640-1,625 cm −1 and 1,750-1,700 cm −1 ranges, respectively, and are generated by the amide I lower frequency vibrational mode of protein β-sheet backbone and by the C0O stretching mode of carbonyl compounds resulting from oxidative stress. The area percentages of β-sheets, which have been obtained by using the peak ratio second-derivative spectral treatment as described above, have been used for ROC analysis to distinguish between patients with AD and age-matched healthy controls. This ROC analysis has shown a good test performance: 90% sensitivity and 90.5% specificity for determinations involving mild and moderate AD patients and agematched healthy controls, and 82.1% sensitivity and 90.5% specificity for determinations involving patients at the three AD stages (mild, moderate, and severe) and age-matched healthy controls. Thus, our study demonstrates that AD is associated with higher percentages of β-structure in mononuclear leukocytes than those in healthy age-matched controls. Therefore, the results described here suggest that peripheral blood can potentially offer a simpler detection of alternative biomarkers of AD. Nevertheless, in order to demonstrate that the aforementioned area percentage of β-structure can be used as a noninvasive marker of peripheral mononuclear leukocytes to diagnose AD in routine patient health screening, it will be necessary to analyze more samples including those from other conditions to know whether or not these conditions generate β-sheet contents similar to those from AD.
